Muhammad Sheikh, MD
Gastroenterology · Fresno, CANPI 1538194048
Payments from drug & device makers
Across 675 payments — averaging $6318.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1.3M
- Intercept Pharmaceuticals, Inc.$987K
- Madrigal Pharmaceuticals$571K
- Genentech, Inc.$488K
- Intercept Pharma Europe Ltd.$288K
- Bausch Health US, LLC$270K
- plus $398K from 22 others
Across 4 payments — averaging $1525.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$6K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 137 | $1,263,992 |
| Intercept Pharmaceuticals, Inc. | 70 | $986,709 |
| Madrigal Pharmaceuticals | 20 | $570,924 |
| Genentech, Inc. | 8 | $487,793 |
| Intercept Pharma Europe Ltd. | 8 | $287,568 |
| Bausch Health US, LLC | 188 | $270,187 |
| Eli Lilly | 8 | $182,759 |
| Gilead | 51 | $148,387 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 120 | $28,626 |
| Phathom Pharmaceuticals, Inc. | 20 | $16,592 |
| Merck | 5 | $11,843 |
| Novartis | 3 | $8,480 |
| Ipsen Biopharmaceuticals, Inc | 6 | $225 |
| Johnson & Johnson(2 entities) | 8 | $198 |
| Boston Scientific | 3 | $118 |
| Sanofi | 4 | $93 |
| Ardelyx, Inc. | 3 | $45 |
| AstraZeneca | 2 | $40 |
| Covidien LP | 1 | $39 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
| Novo Nordisk | 1 | $32 |
| QOL Medical, LLC | 1 | $30 |
| Orphalan Inc | 1 | $28 |
| Celltrion USA Inc. | 1 | $25 |
| Echosens North America, Inc. | 1 | $19 |
| Cook Medical LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
How this compares
$4,264,833 in reported general payments places this provider in the 95th percentile of 1,885 gastroenterology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Fresno
- Peter WinkleCypress$116.7M
- Manuchehr DaraniSanta Ana$17.7M
- Jatinder PruthiLancaster$4.4M
- Long DangWestminster$4.3M
- Gregory WienerChula Vista$3.5M
- Gil MelmedLos Angeles$3M
- Christopher BowlusSacramento$3M
- Bennett RothLos Angeles$2.8M
- Brigid BolandSan Diego$2.4M
- Huy NguyenSan Jose$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.